. . . "Approximately two thirds of patients had a high extent of metastatic disease which, according to the study, meant the cancer had spread to major organs such as the liver, or had spread to four or more bone sites, or both.A significant improvement in overall survival was noted favoring the participants who received docetaxel chemotherapy in addition to ADT compared to those who only received ADT. H" .